These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16210812)

  • 1. Different effects on the inflammatory lesions in the lacrimal and salivary glands after neonatal thymectomy in IQI/Jic mice, a model for Sjögren's syndrome.
    Takada K; Takiguchi M; Inaba M
    J Vet Med Sci; 2005 Sep; 67(9):955-7. PubMed ID: 16210812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialadenitis in IQI/Jic mice: a new animal model of Sjögren's syndrome.
    Saegusa J; Kubota H
    J Vet Med Sci; 1997 Oct; 59(10):897-903. PubMed ID: 9362038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
    Johnson BC; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjogren's syndrome.
    Takada K; Takiguchi M; Konno A; Inaba M
    Rheumatology (Oxford); 2004 Jul; 43(7):858-62. PubMed ID: 15126673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity against a tissue kallikrein in IQI/Jic Mice: a model for Sjogren's syndrome.
    Takada K; Takiguchi M; Konno A; Inaba M
    J Biol Chem; 2005 Feb; 280(5):3982-8. PubMed ID: 15545270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
    Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
    J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
    Hayashi Y; Ishimaru N; Arakaki R; Tsukumo S; Fukui H; Kishihara K; Shiota H; Yasutomo K; Hayashi Y
    Arthritis Rheum; 2004 Sep; 50(9):2903-10. PubMed ID: 15457459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice.
    Sharma R; Zheng L; Guo X; Fu SM; Ju ST; Jarjour WN
    J Autoimmun; 2006 Dec; 27(4):289-296. PubMed ID: 17207605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome.
    Ushio A; Arakaki R; Otsuka K; Yamada A; Tsunematsu T; Kudo Y; Aota K; Azuma M; Ishimaru N
    Front Immunol; 2018; 9():2594. PubMed ID: 30467506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome--close to cause and cure?
    Talal N
    Adv Exp Med Biol; 1994; 350():679-82. PubMed ID: 8030555
    [No Abstract]   [Full Text] [Related]  

  • 11. Sjögren's syndrome in systemic lupus erythematosus. Clinical and subclinical manifestations.
    Alarcón-Segovia D; Ibáñez G; Velázquez-Forero F; Hernández-Ortíz J; González-Jiménez Y
    Ann Intern Med; 1974 Nov; 81(5):577-83. PubMed ID: 4138478
    [No Abstract]   [Full Text] [Related]  

  • 12. Animal models for autoimmune disease-associated xerostomia and xerophthalmia.
    Humphreys-Beher MG
    Adv Dent Res; 1996 Apr; 10(1):73-5. PubMed ID: 8934930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.
    Barr JY; Wang X; Meyerholz DK; Lieberman SM
    Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
    Lieberman SM; Kreiger PA; Koretzky GA
    Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Submandibular and lacrimal gland immunoglobulin in the C3H.MRL-Faslpr autoimmune mouse model of Sjögren's syndrome.
    Trune DR; Leedy DA
    Laryngoscope; 1998 Nov; 108(11 Pt 1):1729-32. PubMed ID: 9818834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of B7-2+ dendritic cells and expression of Th1 cytokines in the early development of sialodacryoadenitis in the IqI/Jic mouse model of primary Sjörgren's syndrome.
    Konno A; Takada K; Saegusa J; Takiguchi M
    Autoimmunity; 2003 Jun; 36(4):247-54. PubMed ID: 14563019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome.
    Fox PC; Speight PM
    Crit Rev Oral Biol Med; 1996; 7(2):144-58. PubMed ID: 8875029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment with oral administration of rebamipide in a mouse model of Sjögren's syndrome.
    Kohashi M; Ishimaru N; Arakaki R; Hayashi Y
    Arthritis Rheum; 2008 Feb; 58(2):389-400. PubMed ID: 18240266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines may prove useful in the treatment of Sjögrens syndrome (SS) dry eye.
    Talal N; Nakabayashi T; Letterio JJ; Kong L; Geiser AG; Dang H
    Adv Exp Med Biol; 1998; 438():953-8. PubMed ID: 9634993
    [No Abstract]   [Full Text] [Related]  

  • 20. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.
    Hayashi T; Shimoyama N; Mizuno T
    Inflammation; 2012 Apr; 35(2):638-46. PubMed ID: 21786007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.